因鼻内使用哌替啶类似物合成产物继发的慢性帕金森综合征。 - Suppr

Suppr

超能文献

Chronic parkinsonism secondary to intranasal administration of a product of meperidine-analogue synthesis.

作者信息

Wright J M, Wall R A, Perry T L, Paty D W

出版信息

N Engl J Med. 1984 Feb 2;310(5):325. doi: 10.1056/NEJM198402023100520.

DOI:10.1056/NEJM198402023100520

PMID:6606784

Abstract

摘要

相似文献

Chronic parkinsonism secondary to intranasal administration of a product of meperidine-analogue synthesis.因鼻内使用哌替啶类似物合成产物继发的慢性帕金森综合征。

N Engl J Med. 1984 Feb 2;310(5):325. doi: 10.1056/NEJM198402023100520.

Street-drug contaminant causing parkinsonism.导致帕金森症的街头毒品污染物。

MMWR Morb Mortal Wkly Rep. 1984 Jun 22;33(24):351-2.

Leads from the MMWR. Street-drug contaminant causing parkinsonism.

JAMA. 1984 Jul 20;252(3):331.

MPTP and parkinsonism.1-甲基-4-苯基-1,2,3,6-四氢吡啶与帕金森症

Ration Drug Ther. 1985 Feb;19(2):5-7.

The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).纹状体多巴胺缺乏的临床综合征。1-甲基-4-苯基-1,2,3,6-四氢吡啶（MPTP）诱发的帕金森综合征。

N Engl J Med. 1985 May 30;312(22):1418-21. doi: 10.1056/NEJM198505303122203.

MPTP toxicity: clinical features.MPTP 毒性：临床特征

J Neural Transm Suppl. 1986;20:5-9.

[MPTP and Parkinson's disease].[1-甲基-4-苯基-1,2,3,6-四氢吡啶与帕金森病]

No To Shinkei. 1988 Nov;40(11):1011-24.

Toxin-induced parkinsonism: recent developments.毒素诱导的帕金森病：最新进展

Am Fam Physician. 1986 Mar;33(3):251-4.

MPTP and the aetiology of Parkinson's disease. Clinical implications. London, June 27, 1985.

J Neural Transm Suppl. 1986;20:1-81.

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): one designer drug and serendipity.1-甲基-4-苯基-1,2,3,6-四氢吡啶（MPTP）：一种合成毒品与意外发现。

J Forensic Sci. 1988 Mar;33(2):588-95.

引用本文的文献

Neuromodulation for obsessive-compulsive disorder.强迫症的神经调节治疗。

Neurotherapeutics. 2014 Jul;11(3):485-95. doi: 10.1007/s13311-014-0287-9.

Considerations on the role of environmental toxins in idiopathic Parkinson's disease pathophysiology.关于环境毒素在特发性帕金森病病理生理学中作用的思考。

Transl Neurodegener. 2014 May 9;3:10. doi: 10.1186/2047-9158-3-10. eCollection 2014.

α-Synuclein and mitochondrial bioenergetics regulate tetrahydrobiopterin levels in a human dopaminergic model of Parkinson disease.α-突触核蛋白和线粒体生物能量学在帕金森病的人类多巴胺能模型中调节四氢生物蝶呤水平。

Free Radic Biol Med. 2014 Feb;67:58-68. doi: 10.1016/j.freeradbiomed.2013.10.008. Epub 2013 Oct 19.

Intranasal administration of neurotoxicants in animals: support for the olfactory vector hypothesis of Parkinson's disease.鼻腔内给予神经毒素在动物体内的作用：支持帕金森病嗅觉神经轴突假说。

Neurotox Res. 2012 Jan;21(1):90-116. doi: 10.1007/s12640-011-9281-8. Epub 2011 Oct 15.

Neurodegeneration and neuroprotection in Parkinson disease.帕金森病中的神经退行性变与神经保护

NeuroRx. 2004 Jan;1(1):139-54. doi: 10.1602/neurorx.1.1.139.

Parkinson's disease in 1984: an update.1984年的帕金森病：最新情况

Can Med Assoc J. 1984 Nov 1;131(9):1031-7.

Electrophysiological and neurochemical correlates of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in the mouse.1-甲基-4-苯基-1,2,3,6-四氢吡啶（MPTP）对小鼠中枢儿茶酚胺能神经元神经毒性作用的电生理和神经化学相关性

Naunyn Schmiedebergs Arch Pharmacol. 1985 Oct;331(1):1-6. doi: 10.1007/BF00498844.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验